Gabelli Funds’s Alder Biopharmaceuticals ALDR Stock Holding History

Gabelli Funds’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-663,555	Closed	-$12.5M	–	1182
2019 Q3	$12.5M	Buy	+663,555	New	+$7.59M	0.08%	296

Gabelli Funds's ALDR Position: Q4 2019 in Review

Gabelli Funds sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 663,555 shares — an estimated $12.5M sold.

Gabelli Funds first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $12.5M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Gabelli Funds reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Gabelli Funds sold 663,555 Alder Biopharmaceuticals shares in Q4 2019, an estimated $12.5M.
Gabelli Funds first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Gabelli Funds's Alder Biopharmaceuticals position peaked at $12.5M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Gabelli Funds's 13F filing for Q4 2019, filed 14 Feb 2020.